Encompass Health Corporation (EHC) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $107.50 (+7.50%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 30, 2025 | Andrew Mok | Barclays | $150.00 | +39.5% |
| Aug 14, 2025 | David MacDonald | Truist Financial | $140.00 | +30.2% |
| Sep 26, 2024 | Ben Hendrix | RBC Capital | $105.00 | -2.3% |
| Sep 25, 2024 | AJ Rice | UBS | $110.00 | +2.3% |
| May 22, 2024 | Frank Morgan | RBC Capital | $95.00 | -11.6% |
| Apr 25, 2024 | Ann Hynes | Mizuho Securities | $95.00 | -11.6% |
| Mar 28, 2024 | Andrew Mok | Barclays | $101.00 | -6.0% |
| Apr 29, 2021 | Scott Fidel | Stephens | $100.00 | -7.0% |
Top Analysts Covering EHC
EHC vs Sector & Market
| Metric | EHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +42.3% | +1150.2% | +14.9% |
| P/E Ratio | 18.41 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.40B | $6.42B | $6.43B | 9 |
| 2027-03-31 | $1.69B | $1.69B | $1.70B | 4 |
| 2027-06-30 | $1.70B | $1.70B | $1.71B | 6 |
| 2027-09-30 | $1.72B | $1.73B | $1.74B | 4 |
| 2027-12-31 | $1.80B | $1.81B | $1.81B | 7 |
| 2028-03-31 | $1.81B | $1.81B | $1.82B | 3 |
| 2028-06-30 | $1.82B | $1.82B | $1.83B | 5 |
| 2028-09-30 | $1.84B | $1.85B | $1.86B | 3 |
| 2028-12-31 | $1.93B | $1.94B | $1.95B | 6 |
| 2029-12-31 | $7.90B | $7.94B | $7.98B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.51 | $5.92 | $6.04 | 8 |
| 2027-03-31 | $1.62 | $1.63 | $1.64 | 3 |
| 2027-06-30 | $1.60 | $1.60 | $1.61 | 3 |
| 2027-09-30 | $1.49 | $1.49 | $1.50 | 4 |
| 2027-12-31 | $1.72 | $1.73 | $1.74 | 3 |
| 2028-03-31 | $1.66 | $1.67 | $1.68 | 4 |
| 2028-06-30 | $1.66 | $1.67 | $1.68 | 4 |
| 2028-09-30 | $1.47 | $1.48 | $1.49 | 6 |
| 2028-12-31 | $1.68 | $1.69 | $1.70 | 4 |
| 2029-12-31 | $7.65 | $7.69 | $7.75 | 1 |
Frequently Asked Questions
What is the analyst consensus for EHC?
The consensus among 1 analysts covering Encompass Health Corporation (EHC) is Buy with an average price target of $153.00.
What is the highest price target for EHC?
The highest price target for EHC is $150.00, set by Andrew Mok at Barclays on 2025-10-30.
What is the lowest price target for EHC?
The lowest price target for EHC is $95.00, set by Ann Hynes at Mizuho Securities on 2024-04-25.
How many analysts cover EHC?
1 analysts have issued ratings for Encompass Health Corporation in the past 12 months.
Is EHC a buy or sell right now?
Based on 1 analyst ratings, EHC has a consensus rating of Buy (2.00/5) with a +42.3% upside to the consensus target of $153.00.
What are the earnings estimates for EHC?
Analysts estimate EHC will report EPS of $5.92 for the period ending 2026-12-31, with revenue estimated at $6.42B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.